Patent · US Active

Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells

US10647718B2 · kind B2 · utility

2Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2015
Grant dateMay 12, 2020
Priority date
Expiry dateOct 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula or salts or prodrugs thereof, are provided and described herein. The compounds are useful to expand hematopoietic stem cell and/or hematopoietic progenitor cell populations. Particularly, the hematopoietic cells are human cells. The compounds are also useful in the medical treatment of hematopoietic disorder/malignancy, an autoimmune disease and/or an inherited immune-deficient disease in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.